BR112018001719A2 - composição farmacêutica com micela polimérica, e, método para preparação de uma composição farmacêutica com micela polimérica. - Google Patents

composição farmacêutica com micela polimérica, e, método para preparação de uma composição farmacêutica com micela polimérica.

Info

Publication number
BR112018001719A2
BR112018001719A2 BR112018001719A BR112018001719A BR112018001719A2 BR 112018001719 A2 BR112018001719 A2 BR 112018001719A2 BR 112018001719 A BR112018001719 A BR 112018001719A BR 112018001719 A BR112018001719 A BR 112018001719A BR 112018001719 A2 BR112018001719 A2 BR 112018001719A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
polymeric micelle
preparing
micelle
polymeric
Prior art date
Application number
BR112018001719A
Other languages
English (en)
Portuguese (pt)
Inventor
Oh Kim Bong
Chan MIN Bum
Rim Kim Hye
Yeong KIM Ji
Jin Kyung Kyu
Hyo Seo Min
Woong Yi Yil
Jeong Yoon Yoo
Original Assignee
Samyang Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals filed Critical Samyang Biopharmaceuticals
Publication of BR112018001719A2 publication Critical patent/BR112018001719A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR112018001719A 2015-07-28 2016-07-28 composição farmacêutica com micela polimérica, e, método para preparação de uma composição farmacêutica com micela polimérica. BR112018001719A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150106628A KR101787447B1 (ko) 2015-07-28 2015-07-28 보관 안정성이 향상된 약학 조성물 및 그의 제조 방법
PCT/KR2016/008269 WO2017018819A1 (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Publications (1)

Publication Number Publication Date
BR112018001719A2 true BR112018001719A2 (pt) 2018-09-18

Family

ID=57884931

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018001719A BR112018001719A2 (pt) 2015-07-28 2016-07-28 composição farmacêutica com micela polimérica, e, método para preparação de uma composição farmacêutica com micela polimérica.

Country Status (13)

Country Link
EP (1) EP3328436A4 (de)
JP (1) JP2018521106A (de)
KR (1) KR101787447B1 (de)
CN (1) CN106659680A (de)
AU (1) AU2016299547A1 (de)
BR (1) BR112018001719A2 (de)
CA (1) CA2993923A1 (de)
HK (1) HK1249440A1 (de)
IL (1) IL257181A (de)
MX (1) MX2018001222A (de)
RU (1) RU2018107054A (de)
WO (1) WO2017018819A1 (de)
ZA (1) ZA201801186B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190231689A1 (en) * 2018-01-29 2019-08-01 Samyang Biopharmaceuticals Corporation Amphiphilic Block Copolymer Composition With Enhanced Micelle Stability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550157B2 (en) * 2000-05-12 2009-06-23 Samyang Corporation Method for the preparation of polymeric micelle via phase separation of block copolymer
US7879317B2 (en) * 2001-10-18 2011-02-01 Samyang Corporation Polymeric micelle compositions with improved stability and methods of making thereof
ATE487134T1 (de) 2007-03-06 2010-11-15 Cell Therapeutics Europe Srl Verfahren zur bestimmung der menge konjugierten taxans in polyglutaminsäure-taxan-konjugaten
KR101024742B1 (ko) * 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
CA2709967C (en) * 2007-12-31 2012-05-29 Samyang Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
EP2201935B1 (de) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymere Mizellenzusammensetzung, die ein schlecht lösliches Arzneimittel enthält, und zugehöriges Herstellungsverfahren

Also Published As

Publication number Publication date
HK1249440A1 (zh) 2018-11-02
EP3328436A4 (de) 2019-03-20
RU2018107054A (ru) 2019-08-28
EP3328436A1 (de) 2018-06-06
KR20170014059A (ko) 2017-02-08
JP2018521106A (ja) 2018-08-02
WO2017018819A1 (en) 2017-02-02
CA2993923A1 (en) 2017-02-02
MX2018001222A (es) 2018-04-24
IL257181A (en) 2018-03-29
ZA201801186B (en) 2018-12-19
CN106659680A (zh) 2017-05-10
RU2018107054A3 (de) 2019-08-28
KR101787447B1 (ko) 2017-10-19
AU2016299547A1 (en) 2018-02-22

Similar Documents

Publication Publication Date Title
CL2016002772A1 (es) Composiciones de insulina de rápida acción
SG10201803042PA (en) Anti-tim-3 antibodies
EP3268435A4 (de) Polymere bodipy-farbstoffe und verfahren zur verwendung davon
BR112018006696A2 (pt) métodos e sistemas para obter óleo a partir de uma composição de vinhoto
BR112015032718A2 (pt) composto de modificação de splicing do gene foxm1, uso do composto, formulação farmacêutica e métodos de triagem de compostos
BR112018002983A2 (pt) composição compreendendo uma lactama e um álcool
BR112016017584A2 (pt) Composições de nanotribologia e métodos relacionados incluindo nanofolhas moleculares
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
EP3130355A4 (de) Pharmazeutische zusammensetzung mit pregabalin mit verbesserter stabilität und verfahren zur herstellung davon
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
EP3409709A4 (de) Photohärtungsverfahren, verbindung und darin verwendete zusammensetzung
HRP20200104T8 (hr) Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto
CY1123408T1 (el) Φαρμακευτικες συνθεσεις και χρηση των αυτων
EA201791716A1 (ru) Фармацевтический состав
BR112016003019A2 (pt) composto, composição farmacêutica, método para tratar câncer em um sujeito com necessidade do mesmo, e método para inibir uma desoxicitidina quinase
EP3252087A4 (de) Zusammensetzung zur formung von leicht abzutrennenden dünnschichtfilmen sowie und leicht abzutrennende dünnschichtfilme
BR112018067656A2 (pt) composições farmacêuticas anti-abuso
BR112018001725A2 (pt) composição farmacêutica com micela polimérica.
EP3278790A4 (de) Antioxidations- oder anti-aging-mittel mit 5-adamantan-1-yl-n-(2,4-dihydroxybenzyl)-2,4-dimethoxybenzamid
BR112018001736A2 (pt) ?composição farmacêutica com micela polimérica?
BR112018001719A2 (pt) composição farmacêutica com micela polimérica, e, método para preparação de uma composição farmacêutica com micela polimérica.
EP3330378A4 (de) Modifizierte sirna und pharmazeutische zusammensetzung damit
EP3304051A4 (de) Verbindungen zur markierung von aminhaltigen verbindungen und deren verwendung
FI20155976A (fi) Menetelmä liima-ainekoostumuksen valmistamiseksi, liima-ainekoostumus ja sen käyttö
BR112018001737A2 (pt) composição farmacêutica com micela polimérica

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]